InvestSMART

Montaka Global Extension Fund (Quoted Managed Hedge Fund) (ASX: MKAX) - Announcements

Current share price for MKAX : $3.950 0.09 (2.23%)+

Montaka Global Extension Fund (Quoted Managed Hedge Fund) (MKAX) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Montaka Global Extension Fund (Quoted Managed Hedge Fund) (MKAX) is a global equities manager with offices in Sydney, Melbourne and New York. The Fund seeks to invest in a portfolio of high-quality global equities listed on major global exchanges (the Long Portfolio) purchased at a discount to our estimate of their intrinsic value.

Latest company announcements for Montaka Global Extension Fund (Quoted Managed Hedge Fund) (MKAX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$78 MKAX Quarterly Portfolio Disclosure - 31 Mar 25 19 May 2025 11:49AM $4.040 $3.950 fallen by 2.23%
$78 MKAX April 2025 Monthly Report 15 May 2025 2:40PM $4.130 $3.950 fallen by 4.36%
$78 MKAX - Monthly Redemption and Units on Issue - April 2025 6 May 2025 4:12PM $3.790 $3.950 risen by 4.22%
$78 MKAX - Monthly Prime Brokerage Disclosure - 30 April 2025 6 May 2025 4:09PM $3.790 $3.950 risen by 4.22%
$78 Change of address 5 May 2025 11:42AM $3.810 $3.950 risen by 3.67%
$78 MKAX March 2025 Monthly Report 17 Apr 2025 9:19AM $3.460 $3.950 risen by 14.16%
$78 MKAX - Monthly Prime Brokerage Disclosure - 31 March 2025 4 Apr 2025 2:30PM $3.470 $3.950 risen by 13.83%
$78 MKAX - Monthly Redemption and Units on Issue 4 Apr 2025 10:37AM $3.690 $3.950 risen by 7.05%
$78 MKAX SPDS April 2025 1 Apr 2025 1:52PM $3.670 $3.950 risen by 7.63%
$78 MKAX February 2025 Monthly Report 14 Mar 2025 3:05PM $3.730 $3.950 risen by 5.90%
$78 MKAX - Monthly Prime Brokerage Disclosure - 28 February 2025 5 Mar 2025 11:29AM $4.090 $3.950 fallen by 3.42%
$78 MKAX - Monthly Redemption and Units on Issue - February 2025 5 Mar 2025 11:28AM $4.090 $3.950 fallen by 3.42%
$78 MKAX - Financial Statements 31 Dec 2024 28 Feb 2025 9:19AM $4.200 $3.950 fallen by 5.95%
$78 MKAX Quarterly Portfolio Disclosure - 31 Dec 24 25 Feb 2025 1:24PM $4.250 $3.950 fallen by 7.06%
$78 MKAX January 2025 Monthly Report 13 Feb 2025 4:11PM $4.480 $3.950 fallen by 11.83%
$78 MKAX - Monthly Prime Brokerage Disclosure - 31 January 2025 6 Feb 2025 10:01AM $4.590 $3.950 fallen by 13.94%
$78 MKAX - Monthly Redemption and Units on Issue - January 2025 5 Feb 2025 3:02PM $4.590 $3.950 fallen by 13.94%
$78 Letter MFF Montaka - Acquisition 4 Feb 2025 4:40PM $4.640 $3.950 fallen by 14.87%
$78 MKAX December 2024 Monthly Report 14 Jan 2025 11:52AM $4.320 $3.950 fallen by 8.56%
$78 Q4 2024 Quarterly Update Letter 14 Jan 2025 11:52AM $4.320 $3.950 fallen by 8.56%
$78 MKAX - Distribution - 31 Dec 2024 13 Jan 2025 4:20PM $4.320 $3.950 fallen by 8.56%
$78 MKAX November 2024 Monthly Report 6 Jan 2025 4:09PM $4.460 $3.950 fallen by 11.43%
$78 MKAX - Monthly Redemption and Units on Issue - December 2024 6 Jan 2025 9:37AM $4.440 $3.950 fallen by 11.04%
$78 MKAX - Monthly Prime Brokerage Disclosure - 31 December 2024 3 Jan 2025 4:42PM $4.440 $3.950 fallen by 11.04%
$78 MKAX - Estimated Distribution - 31 Dec 2024 20 Dec 2024 3:51PM $4.510 $3.950 fallen by 12.42%

1 - 25 of 231 results

Page 1 of 10

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.